This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Changing R&D models in research-based pharmaceutical companies
Journal of Translational Medicine Open Access 27 April 2016
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Change history
09 January 2012
In the version of this article initially published, Gilead Biosciences was incorrectly named. The correct name is Gilead Sciences. The error has been corrected in the HTML and PDF versions of the article.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kling, J. Biotechs follow big pharma lead back into academia. Nat Biotechnol 29, 555–556 (2011). https://doi.org/10.1038/nbt0711-555
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0711-555
This article is cited by
-
Changing R&D models in research-based pharmaceutical companies
Journal of Translational Medicine (2016)
-
Erratum: Corrigendum: Biotechs follow big pharma lead back into academia
Nature Biotechnology (2012)
-
New models emerge for commercializing university assets
Nature Biotechnology (2011)